Literature DB >> 3966489

Infectious peritonitis in patients receiving intraperitoneal chemotherapy.

R A Kaplan, M Markman, W E Lucas, C Pfeifle, S B Howell.   

Abstract

A total of 32 episodes of infectious peritonitis developed in 90 patients receiving intraperitoneal chemotherapy. Staphylococcus epidermidis was the organism most commonly cultured, accounting for 65 percent of isolates. Result of initial gram stain was positive in 35 percent of cases. The development of fever and abdominal pain as well as rising peripheral and peritoneal fluid white blood cell counts was helpful in the making of a diagnosis of infectious peritonitis. Seventy-five percent of patients were cured with antibiotic therapy alone whereas one quarter also required removal of the semi-permanent catheter. Patients treated with intraperitoneal chemotherapy delivered by dialysis exchange over several days exhibited significantly more episodes of infection than patients treated by a single-drug instillation each month. Although the development of bacterial peritonitis remains a problem during intracavitary chemotherapy, the use of subcutaneous ports and meticulous sterile technique during catheter manipulation will hopefully decrease the risk of occurrence of this potentially avoidable complication.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3966489     DOI: 10.1016/0002-9343(85)90461-9

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  4 in total

1.  Reduction of the local toxicity of intraperitoneal chemotherapy; an experimental model.

Authors:  R G Molloy; B Crowley; K T Moran; M P Brady
Journal:  Ir J Med Sci       Date:  1990-06       Impact factor: 1.568

2.  Phase I and pharmacokinetic study of high volume intraperitoneal aclacinomycin-A (Aclarubicin).

Authors:  I G Kerr; S Archer; C DeAngelis; S Farrell; S Hanna; J McKee
Journal:  Invest New Drugs       Date:  1987       Impact factor: 3.850

Review 3.  Intraperitoneal therapy in the management of ovarian carcinoma.

Authors:  M Markman; T Hakes; B Reichman; W Hoskins; S Rubin; W Jones; L Almadones; J L Lewis
Journal:  Yale J Biol Med       Date:  1989 Jul-Aug

Review 4.  Albumin-based cancer therapeutics for intraperitoneal drug delivery: a review.

Authors:  Leen Van de Sande; Sarah Cosyns; Wouter Willaert; Wim Ceelen
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.